Showing results (231-240 of 634) with videos related to

Sort By:
Pageof 64
Surgery|August 11, 2022
Preoperative assessment of microvessel density in nonfunctioning pancreatic neuroendocrine tumors (NF-PanNETs)Anna Battistella, Stefano Partelli, Valentina Andreasi, et al.
Frontiers in Oncology|June 22, 2023
Role of pancreatic ductal adenocarcinoma risk factors in intraductal papillary mucinous neoplasm progressionManuel Gentiluomo, Chiara Corradi, Paolo Giorgio Arcidiacono, et al.
Annals of Surgical Oncology|October 13, 2022
CA19.9 Response and Tumor Size Predict Recurrence Following Post-neoadjuvant Pancreatectomy in Initially Resectable and Borderline Resectable Pancreatic Ductal AdenocarcinomaLaura Maggino, Giuseppe Malleo, Stefano Crippa, et al.
Gastrointestinal Endoscopy|January 18, 2026
Long-term Outcomes of EUS-guided Gastroenterostomy (LONG-RANGE study): a prospective cohort study tracking symptom recurrence, reintervention timelines and stent modifications over timeGiuseppe Vanella, Francesco Frigo, Francesca Perelli, et al.
JAMA Surgery|July 24, 2024
Futility of Up-Front Resection for Anatomically Resectable Pancreatic CancerStefano Crippa, Giuseppe Malleo, Vincenzo Mazzaferro, et al.
Annals of Surgery|March 26, 2008
Mucinous cystic neoplasm of the pancreas is not an aggressive entity: lessons from 163 resected patientsStefano Crippa, Roberto Salvia, Andrew L Warshaw, et al.
European Journal of Cancer (Oxford, England : 1990)|August 28, 2018
A randomised phase 2 trial of nab-paclitaxel plus gemcitabine with or without capecitabine and cisplatin in locally advanced or borderline resectable pancreatic adenocarcinomaMichele Reni, Silvia Zanon, Gianpaolo Balzano, et al.
Expert Opinion on Pharmacotherapy|September 29, 2020
Use of octreotide long acting repeatable (LAR) as second-line therapy in advanced neuroendocrine tumors in different clinical settings: an Italian Delphi surveyMassimo Falconi, Nicola Fazio, Diego Ferone, et al.
Annals of Surgery|June 9, 2017
A New Scoring System to Predict Recurrent Disease in Grade 1 and 2 Nonfunctional Pancreatic Neuroendocrine TumorsCansu G Genç, Anneke P Jilesen, Stefano Partelli, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|November 8, 2024
Pig Xenotransplantation in Beta Cell Replacement: Addressing Challenges and Harnessing Potential for Type 1 Diabetes TherapyLorenzo Piemonti, Antonio Citro, Valentina Tomajer, et al.
Pageof 64